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mies L, Honkanen-Buzalski T: Antimicrobial resistance in Staphylococcusspp., Es-
cherichia coli and Enterococcus spp. in dogs given antibiotics for chronic dermato-
logical disorders, compared with non-treated control dogs. Acta vet. scand. 2004,
45, 37-45. - The aim of this study was to evaluate antimicrobial resistance in canine
staphylococci, Escherichia coli and enterococci, which were isolated from 22 dogs with
pyoderma and a history of previous antibiotic treatment, compared to bacterial isolates
from 56 non-treated control dogs. Two isolates of each bacterial species per dog were in-
vestigated, if detected. Staphylococcal isolates from dogs with pyoderma (35 isolates)
were more resistant to sulphatrimethoprim than the isolates from controls (56 isolates)
(57% vs. 25%, p<0.004). Multiresistance in staphylococci was also more common in
dogs with pyoderma (29% vs. 9%, p=0.02). A similar trend among isolates of E. coli
was detected (24 and 74 isolates from treated and control dogs, respectively), but the dif-
ferences were not signiﬁcant. Resistance for macrolide-lincosamides was approxi-
mately 20% among staphylococci in both groups.  Resistance to ampicillin among en-
terococci was 4%-7%. The age of the dogs might have an impact on resistance:
multiresistance among staphylococcal isolates from younger dogs (≤5 years) was more
common than in older dogs (≥6 years) (24%, vs. 0%, 63 and 27 isolates, respectively,
p=0.02). Staphylococci in younger dogs were more resistant to tetracycline (48% vs.
11%, p<0.001) and sulphatrimethoprim (48% vs. 15%, p<0.01) than those in older dogs.
In contrast, the isolates of E. coli from older dogs tended to be more resistant, although
a signiﬁcant difference was detected only in resistance to tetracycline (13% vs. 2% of
40 and 50 isolates respecthely, p=0.04)). The results of this small study indicate that re-
sistance in canine staphylococci in the capital area of Finland is comparable with many
other countries in Europe. Resistance in indicator bacteria, E. coli and enterococci, was
low.
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Introduction
Staphylococcus intermedius, as well as other
staphylococci, is habitant of the normal bacte-
rial ﬂora of the dog and can be isolated from
healthy dogs, especially from the anal region
(Devriese & DePelsmaeker 1987).  S. inter-
medius is also an important skin pathogen in
dogs (Medleau et al. 1986). Antimicrobial re-
sistance among canine staphylococci is com-mon (Noble & Kent 1992, Lloyd et al. 1996,
Werckenthin et al. 2001, Holm et al. 2002). In
addition, bacteria of the normal ﬂora of the gut,
such as Escherichia coliand Enterococcusspp.,
can easily acquire and transfer resistance genes.
These bacteria can thus be used as indicators of
changes in antimicrobial resistance (Caprioli et
al. 2000). Regular monitoring of the level of re-
sistance in pathogens and bacteria of the nor-
mal ﬂora has been recommended (Martel et al.
2001). Monitoring programmes for antimicro-
bial resistance have been established in veteri-
nary medicine, but only for food producing an-
imals (Martel et al. 2001). Not many reports of
the level of antimicrobial resistance in canine
normal ﬂora have been published (Hirsh et al.
1980, Monaghan et al. 1981, Devriese et al.
1996, van Belkum et al. 1996). The aim of this
study was to investigate whether the bacteria of
the normal ﬂora are more resistant in dogs,
which have received antimicrobials for the
treatment of chronic dermatological disorders,
when compared to the bacteria of non-treated
control dogs. We chose to study staphylococci,
E. coli, Enterococcus faecalis and Enterococ-
cus faecium.
Materials and methods
Sampling
Dogs with chronic dermatological disorders
(n=22) treated with antimicrobials during the 6
months preceding the study were sampled in
the treated group. The last treatment was to
have ended at least 2 weeks before the samples
were taken. Dogs in the control group (n=56)
were presented to a veterinarian for other rea-
sons and had not received antimicrobials during
the previous 6 months. The following data were
collected from the patients: breed, age, sex, an-
timicrobials given during the previous 6 months
and the duration of the treatment.
Samples were collected at the Small Animal
Veterinary Teaching Hospital of the Helsinki
University and at 2 veterinary clinics in the
same area between December 1997 and July
1998. For the isolation of staphylococci, a sam-
ple was taken by swabbing the perianal mucosal
area with a sterile cotton swab. For the isolation
of E. coli and enterococci, a faecal sample was
taken from the rectum with a sterile glove. Sam-
ples were directly transported to the National
Veterinary and Food Research Institute, Hel-
sinki, Finland, where the bacteriological analy-
sis was carried out immediately after sample ar-
rival. If samples were taken during a weekend,
they were ﬁrst stored at +4°C and then trans-
ported to be analysed on Monday.   
Isolation and identiﬁcation of bacteria
For the isolation of staphylococci, samples
were streaked onto 5% bovine blood agar and
Staphylococcus medium 110 -agar (Difco Lab-
oratories, Detroit, Michigan, USA) and incu-
bated at 37°C for 18-24 h. Identiﬁcation to the
species level was performed by conventional
methods (Quinn et al. 1994). 
For the isolation of E. coli, faecal samples were
cultured on Rapid E. coli -agar (Sanoﬁ Diag-
nostics, Marnes La Coquette, France) and incu-
bated at +44ºC for 24 h. Five blue colonies were
picked, streaked onto blood agar and incubated
further at +37°C for 24 h. E. coli was identiﬁed
by colony morphology, oxidase and indole
tests. The identity was further conﬁrmed with
API20E (bioMérieux, Marcy l'Etoile, France).
For the isolation of enterococci, faecal samples
were inoculated onto Slanetz-Bartley agar
(Merck, Darmstadt, Germany) and incubated at
+44ºC for 48 h. Five red colonies were subcul-
tured on Tryptone soya agar (BBL, Cock-
eysville, Maryland, USA) and incubated at
37°C for 24 h. Isolates were identiﬁed as ente-
rococci on the basis of colony morphology on
Slanetz-Bartley agar, a negative catalase test
and the ability to grow in Brain Heart Infusion
(BHI) (Difco Laboratories) containing 6.5%
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were identiﬁed on the basis of tests for motility,
fermenting reactions with L-arabinose, manni-
tol, melibiose, rafﬁnose and sorbitol. The iden-
tiﬁcation of isolates was further conﬁrmed with
APIStrept (bioMérieux, Marcy l'Etoile, France).
If  Staphylococcus spp.,  E. coli, E. faecium
and/or E. faecalis were identiﬁed, 2 colonies
per sample were stored in BHI supplemented
with glycerol at -70°C. 
Antimicrobial susceptibility testing
Antimicrobial susceptibility of the isolates was
determined by the agar diffusion test on Iso-
Sensitest agar (CM471, Oxoid, Basingstoke,
UK) according to NCCLS standards (1997).
Antimicrobial disks were from Oxoid. The
breakpoint zone diameters used in the study,
and respective minimum inhibitory concentra-
tions (MIC), if available, are presented in Table
1. In addition, for staphylococci, the ability to
produce ß-lactamase was tested (Nitroceﬁn,
AB Biodisk, Sweden). Both resistant and inter-
mediate isolates are reported as resistant when
interpreting resistance percentages. An isolate
was deﬁned multiresistant if it showed resis-
tance to 3 or more different classes of antimi-
crobials.  E. coli (ATCC 25922), E. faecalis
(ATCC 29212) and Staphylococcus aureus
(ATCC 25923) were used as controls.
Five staphylococcal isolates, which ﬁrst gave an
unusual macrolide resistance pattern (isolates
Antimicrobial resistance in dogs 39
Acta vet. scand. vol. 45 no. 1-2, 2004
Table 1. Susceptibility breakpoint zone diameters (mm) used in the study. 
Staphylococci E.coli Enterococci Respective MIC -value for
susceptible srains *
Betalactams
Penicillin G 10 IU ≥29 ≤0.12 µg /ml
Ampicillin 10 µg ≥17 ≥17 ≤8 µg /ml
Amoxillin-clavulanate (2:1) 30 µg ≥17 -
Cephalotin 30 µg  ≥18 ≤8 µg /ml
Cefotaxime 30 µg ≥18 -
Oxacillin 1 µg ≥13 ≤2 µg /ml
Macrolides and lincosamides
Erythromycin 15 µg ≥16 -
Clindamycin 2 µg ≥21 ≤0.5 µg /ml
Aminoglycosides
Streptomycin 10 µg ≥15 -
Gentamicin 10 µg ≥19 -
Others
Chloramphenicol 30 µg ≥20 -
Enroﬂoxacin 5 µg ≥21 ≤0.25 µg /ml
Trimethoprim/sulfamethoxazole  ≥16 ≥16 ≤2/38 µg /ml
1.25/23.75 mg (SXT)
Tetracycline 30 µg ≥21 ≥19 for  E.coli: ≤4 µg /ml
Vancomycin 30 µg ≥18 -
*The respective MIC -value is, if found, from the NCCLS standards. Susceptibility breakpoints are those used by The National
Veterinary and Food Research Institute at the time this study was made, and they partly differed from the NCCLS (1997) stan-
dards.resistant or intermediate to clindamycin but
sensitive to erythromycin) were re-tested both
with E-test (AB-Biodisk, Solna, Sweden) and
disk diffusion test. The susceptibility break-
point in E-test both to erythromycin and clin-
damycin was MIC ≤0.5 µg/ml. The phenotypes
of these isolates were tested with double-disk
method (Leclercq & Courvalin 1991). Entero-
coccal isolates, which had reduced susceptibil-
ity to vancomycin according to the disk diffu-
sion test, were tested on the presence of van
-genes with a multiplex PCR (polymerase chain
reaction) detection at a National Public Health
Institute with the method described by Patel et
al. (1997). 
Statistical analysis
The results are presented as the number of bac-
terial isolates. Fisher's 2-tailed exact test was
used to compare resistance in bacterial isolates
between the 2 groups. The statistical analysis
was made with the SAS software. Difference
between the groups was considered signiﬁcant
if p≤0.05. 
Results
A total of 56 dogs, with a median age of 5 years,
were included in the control group, and 22
dogs, with a median age of 3 years in the treated
group. Of the treated dogs, 9 had received an-
timicrobials during at least 2 treatment periods
lasting more than 3 weeks, and the rest of the
dogs were given antibiotics for less than 3
weeks. The number of treatment periods with
antimicrobials in dermatological patients was:
cephalexin 14, amoxicillin-clavulanate 4, amo-
xicillin 3, penicillin V 2, sulphatrimethoprim
(SXT) 1 and clindamycin 1. Information on the
antimicrobial agent used was missing for 4
dogs with pyoderma. The number of investi-
gated bacterial isolates in the control and
treated group, respectively, was as follows:
Staphylococcus spp. 56/35, E. coli 74/24, E.
faecalis 28/21 and E. faecium 45/16. The re-
spective mean number of bacterial isolates in-
vestigated per dog was: Staphylococcus spp.
1.8/1.8, E. coli 1.9/1.8, E. faecalis 1.6/1.9 and
E. faecium 1.9/1.8. The number in parentheses
(n) hereafter is the number of bacterial isolates,
if not stated otherwise. 
The staphylococcal isolates of the treated dogs
were more resistant to SXT compared to those
of the control group (57%, n=35 and 25%,
n=56, respectively, p<0.004, Fig. 1). Multiresis-
tant staphylococci were also more common in
the treated group (29% vs. 9%, p=0.02). The
most common multiresistant phenotypes
were penicillin-SXT-tetracycline-macrolide/
lincosamides (n=4) and penicillin-SXT-tetracy-
cline (n=4). ß-lactamase production was de-
tected in 71% of the staphylococcal isolates in
the treated group and in 75% of the isolates in
the control group. No differences were detected
in macrolide-lincosamide resistance between
the groups: among control group staphylo-
cocci, the level of resistance both to ery-
thromycin and clindamycin was 21%. 20% of
staphylococcal isolates from treated dogs were
resistant to erythromycin and 16% were resis-
tant to clindamycin. Phenotypes of 5 staphylo-
coccal isolates, which ﬁrst gave unusual
macrolide-lincosamide resistant pattern, were
as follows: 3/5 showed inducible resistance to
the macrolide-lincosamides, and 2/5 were sus-
ceptible to macrolide-lincosamides. No resis-
tance to oxacillin, amoxicillin-clavulanate and
ﬁrst generation cephalosporins was detected.
Isolates of E. coli from dogs in the treated
group tended to be more resistant to sul-
phatrimethoprim, streptomycin and ampicillin,
but the differences were not statistically signif-
icant (Fig. 1). No resistance to gentamycin or
cefotaxime was detected.
Among enterococci, the resistance to ampicillin
was low in both groups (4%-7%) and there was
no difference between the groups. Two E. fae-
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Figure 1. Upper panel: percentage of resistant staphylococcal isolates from control and treated dogs. Middle
panel: respective results of E.coli. Lower panel: resistance in staphylococcal isolates from younger and older
dogs regardless of treatment history. Signiﬁcant differences marked by an asterisk. Abbreviations: ß-lact+ = be-
talactamase positive, amp=ampicillin, clin=clindamycin, ery=erythromycin, strep=streptomycin, sxt=sul-
phatrimethoprim, tet=tetracyclin, >1=resistant to one or more antimicrobials, multires=multiresistant isolates
(resistant to three or more different class of antimicrobials).
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Resistance in Staphylococcus spp.
isolates within two age groupscalis isolates from 2 control dogs were classi-
ﬁed as resistant to vancomycin, but no van -
genes were present in multiplex PCR testing.
None of E. faecium isolates were resistant to
vancomycin. 
The impact of the age of the dog on the results
was further studied by dividing the dogs into 2
age groups (≤0-5 years, and ≥6 years) regard-
less of the previous treatment history. Multire-
sistant staphylococcal isolates were more com-
monly found in younger than older dogs (24%,
n=63 vs. 0%, n=27, p=0.02) Staphylococcal
isolates from younger dogs were also more re-
sistant to tetracycline (48% vs. 11%, p<0.001)
and SXT (48% vs. 15%, p<0.01, Fig. 1). E. coli
isolates showed the opposite pattern in resis-
tance: isolates from older dogs tended to be
more resistant compared with isolates from
younger dogs, but a signiﬁcant difference was
detected only in the resistance to tetracycline
(13%, n=40 vs. 2%, n=58, p=0.04). 
Discussion
The ﬁndings of this study indicate that antimi-
crobial resistance in canine staphylococci is at a
similar level in the capital area of Finland com-
pared with studies from Norway (Kruse et al.
1996), Sweden (Holm et al. 2002), France (Pel-
lerin et al. 1998), Denmark (Pedersen & We-
gener 1995), USA, UK and Germany (Werck-
enthin et al. 2001). Betalactamase production
among canine S. intermedius has been reported
to be common, 50%-90% of isolates produce
betalactamase (Noble & Kent 1992, Pedersen &
Wegener 1995, Kruse et al. 1996, Lloyd et al.
1996, Holm et al. 2002). 
In spite of an extensive use of ﬁrst generation
cephalosporins and other ß-lactamase stable an-
timicrobials in the canine practice, resistance to
oxacillin is still rather rare (Pedersen & We-
gener 1995,  Kruse et al. 1996,  Lloyd et al.
1996), although methicillin resistance in canine
staphylococci has been reported to occur (Piritz
et al. 1996, Gortel et al. 1999, Pak et al. 1999).
It should also be noted that the routine disk dif-
fusion test is not optimal for detecting methi-
cillin resistance (Gortel et al. 1999). In our
study, resistance to ﬁrst generation cephalo-
sporins or oxacillin was not detected. 
The level of SXT resistance among canine S.
intermedius varies in different countries. In our
study, SXT resistance was more common in
staphylococci isolated from treated dogs (57%)
compared to controls (25%). Pellerin et al.
(1998) reported similar resistance ﬁgures to
SXT among S. intermedius isolates from
healthy dogs in France. In the same study, how-
ever, resistance among S. intermedius isolated
from dogs with pyoderma increased from 6% to
36% during a 9-year follow-up period. In con-
trast, in the UK, resistance to SXT in staphylo-
cocci from canine pyoderma cases peaked at
15% in 1989, but fell to 8% by 1995 (Lloyd et
al. 1996). Interestingly, in Norway and in Den-
mark, despite of extensive use of SXT products
in canine practice, resistance to this agent was
very low (1% and 0%) in 1996 (Pedersen & We-
gener 1995,  Kruse et al. 1996). Due to the
molecular genetics of SXT resistance, removal
of the selection pressure will not have an im-
mediate impact on the level of resistance
(Huovinen et al. 1995). 
The relatively high macrolide-lincosamide re-
sistance (on average 20%) in canine staphylo-
cocci in this study might be explained by an in-
creased use of these antimicrobials in dogs
during the last decades in our country. Simi-
larly, Kruse et al. (1996) reported from 3% to
25% increase in resistance to macrolide-lin-
cosamide antimicrobials during 1987-1994 in
canine staphylococci in Norway, which was
probably due to an increased use of these drugs.
In France, macrolide-lincosamide resistance in
canine staphylococci was as high as 40% (Pel-
lerin et al. 1998). Usually, as a rule, bacteria
which are resistant to clindamycin are also re-
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they thus show MLSB phenotype (resistance to
macrolide-lincosamide-streptogramin-B anti-
microbials), which is mediated by erm -methy-
lase genes (Leclercq & Courvalin 1991). In the
study by Boerlin et al. (2001) it was reported
that all erythromycin resistant canine S. inter-
medius strains carried erm(B)-gene. Interest-
ingly, Malbruny et al. (2002) described one hu-
man strain of Streptococcus pyogenes, which
showed resistance to clindamycin (≥MIC 2
µg/ml) but not to erythromycin in MIC-testing.
Since the strain showed resistance to
azithromycin, they still considered it to be of
the MLSB -phenotype. However, this strain did
not carry any erm -genes, but instead a point
mutation in 23S rRNA was found. Since the
number of reports from macrolide resistance
mechanisms in canine gram-positive bacteria is
scarce, more studies will be needed. 
Faecal gram-negative bacteria and enterococci
are considered to be good indicators of the se-
lection pressure caused by the use of antimicro-
bials (Caprioli 2000). In our study, the level of
resistance was low in canine enterococci and E.
coli isolates. Monaghan et al. (1981) investi-
gated E. coli strains from healthy urban and ru-
ral dogs and observed more multiresistance in
E. coli isolates from rural dogs living on dairy
farms than in E. coli isolates from urban dogs.
These dogs had not received antimicrobials, but
the selection pressure was supposed to be de-
rived from antimicrobials used for cows. Hirsh
(1973) reported that 69% of E. coli strains iso-
lated from canine urinary infections were resis-
tant to at least 2 antimicrobials, and multiresis-
tance was also common among patients who
had not received antimicrobials before. The in-
cidence of R-plasmids has been shown to be
common in the faecal ﬂora of healthy dogs
(Hirsh et al. 1980) 
Resistance to ampicillin in enterococci was low
in our study, and no differences were detected
between the groups. Two (2/49) E. faecalis iso-
lates had reduced susceptibility to vancomycin
according to disk diffusion test, but these iso-
lates did not carry any van -genes and thus were
not real VRE isolates (=vancomycin resistant
enterococcus). None of the 61 E. faecium iso-
lates was resistant to vancomycin. Vancomycin
resistant enterococci in dogs have been reported
in other studies, probably due to avoparcin use
in farm animals (Van Belkum et al. 1996). The
VRE prevalence in enterococci from Dutch
dogs was 48%, and half of these carried an
identical  van(A)-gene found also in human
VRE -strains (Van Belkum et al. 1996). In Bel-
gium, 8% of canine enterococci were resistant
to vancomycin and also carried the van(A)-
gene (Devriese et al. 1996). The use of avo-
parcin was banned in Finland in 1995, and the
use of vancomycin for the treatment of animals
is legally prohibited. 
According to our results, the effect of age on re-
sistance would need more studies, although ma-
terial in this study was too small to do any fur-
ther conclusions. In humans, Arstila et al.
(1994) reported increased resistance among
urinary E. coli isolates with increasing age, but
they were not able to conclude if this was due to
the ageing or the cumulative lifetime use of an-
timicrobials. We were not able to ﬁnd reports
where the effect of age on resistance had been
studied in dogs. 
In conclusion, our results support the fact that
the use of antimicrobials, and the development
of and prevailing antimicrobial resistance
among bacteria are linked together. Although
resistance among indicator bacteria was found
to be low, resistance in staphylococci to com-
monly used antimicrobials is widespread: the
efﬁcacy of sulphatrimethoprim and macrolides
is at risk to deteriorate. The rather high preva-
lence of multiresistant strains among canine
staphylococci is also a phenomenon, which
gives cause for concern. In order to detect early
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high prevalence of resistance is selected or de-
veloped, regular monitoring of antimicrobial
resistance both among pathogenic bacteria and
normal ﬂora of companion animals will be
needed. The genetic mechanisms, which medi-
ate antimicrobial resistance in these bacteria,
would also need further studies.  
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Sammanfattning
Antibiotika resistens hos Staphylococcus spp.,
Escherichia coli och Enteroccus spp. isolerade från
hundar med kroniska dermatologiska sjukdomar, i
förhållande till friska hundar.
Målet med denna studie var att jämföra stafylokock-
ers, E. colis och enterokockers antibiotikaresistens
hos hundar med pyoderma (n=22), vilka tidigare be-
handlats med antibiotika, med antibiotikaresistensen
hos icke-behandlade kontrollhundar (n=56). Resi-
stens mot sulfatrimetoprim var mer allmänn hos sta-
fylokocker från hundar med pyoderma (35 isolat) än
stafylokocker från kontrollhundar (56 isolat) (57%
vs. 25%, p< 0.004). Stafylokocker var mera multire-
sistenta hos hundar med pyoderma (29% vs. 9%,
p=0.02). En liknande trend kunde konstateras även
hos E. coli(24 isolat från pyoderma och 74 isolat från
kontrolhundar), men skillnaden var inte signiﬁkant.
Ampicillin resistens var 4%-7% hos Enterococcus
spp. isolat. 
Hundens ålder kan ha betydelse för resistensen - mul-
tiresistenta stafylokocker var vanligare hos yngre
hundar (≤5 år) än hos äldre (≥6 år) (24% vs. 0%,
n=63 respektive 27, p=0.02). Stafylokocker isolerade
från yngre hundar var oftare resistenta mot tetracyk-
lin och sulfatrimetoprim. Däremot var E. coli från
äldre hundar mera resistenta, men en signiﬁkant
skillnad kunde konstateras enbart mot tetracyklin
(12.5% vs. 1.7%, n=40 respektive 58, p=0.04). Re-
sultaten från denna lilla studie visar att resistensen
hos stafylokocker hos hundar i Finland är jämförbar
med resistensen i många andra länder i Europa. Resi-
stensen hos E. coli och enterokocker verkar däremot
vara låg i Finland.
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